Board

Chairman of the board with more than 35 years in general management level in various Science Parks, IT companies and start-ups with extensive experience in all areas of innovation promotion, consulting, sales and marketing.

CEO and cofounder of Truly Labs AB and Truly Translational Sweden AB. Ph. D. In Immunotechnology from Lund University and Marketing Economist (EFL). Broad experience of early stage pharmaceutical development of small molecules and biopharmaceuticals from BioInvent, Pharmacia Upjohn, Active Biotech and AstraZeneca.

Principal Scientist and cofounder of Truly Labs AB. Extensive experience of the pharmaceutical industry with more than twenty years of drug discovery, in vivo pharmacology, and line management functions and thereafter management of clinical studies.

Senior Advisor at R & R Partners. Educated at Stockholm School of Economics in Business Administration and Economics. Experienced CFO and CEO from Medical device (Althin Medical) and Private Equity (Esalp Invest AB) business.

CSO and cofounder of Truly Labs AB and Truly Translational Sweden AB. Ph. D. In Medical Sciences from Lund University. Broad experience within In vivo pharmacology and pharmaceutical development of small molecules as well as biologics from Pharmacia Upjohn, Active Biotech, Cartela and AstraZeneca.

Senior Director Software Development at IKEA. M Sc in Computer Science and Engineering from Lund. 15+ years in Pharmaceutical R&D Digital in roles as VP Research Informatics, Novo Nordisk, and Global IT Director, AstraZeneca R&D, in Sweden, UK and Denmark. Delivered Alfa Laval IT transformation programme as Chief Architect.